Hammer Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$713K Sell
6,657
-1,015
-13% -$97.5K 3.45% 2
2020
Q3
$672K Sell
7,672
-3,885
-34% -$366K 2.99% 8
2020
Q2
$1.14M Sell
11,557
-1,111
-9% -$97.8K 3.25% 6
2020
Q1
$965K Sell
12,668
-24,308
-66% -$2.07M 3.04% 10
2019
Q4
$3.27M Sell
36,976
-513
-1% -$42.6K 2.47% 13
2019
Q3
$2.84M Buy
37,489
+100
+0.3% +$6.86K 2.26% 19
2019
Q2
$2.72M Sell
37,389
-587
-2% -$46.1K 2.25% 19
2019
Q1
$3.06M Sell
37,976
-94
-0.2% -$7.69K 2.7% 14
2018
Q4
$3.51M Sell
38,070
-49
-0.1% -$4.31K 3.43% 4
2018
Q3
$3.6M Sell
38,119
-3,467
-8% -$329K 2.95% 5
2018
Q2
$7.33M Buy
+41,586
New +$4.06M 6.42% 1

Other funds holding ABBV

Hammer Asset Management's ABBV Position: Q4 2020 in Review

Hammer Asset Management reduced its AbbVie (ABBV) stake by 13% in Q4 2020, selling an estimated $97.5K and leaving 6,657 shares worth $713K. The position accounts for 3.45% of the portfolio, ranked #2.

Hammer Asset Management first reported a position in ABBV in Q2 2018 and has held it in 11 quarters since. The position peaked at $7.33M in Q2 2018. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Hammer Asset Management held 6,657 shares of AbbVie worth $713K as of Q4 2020.
  • Hammer Asset Management sold 1,015 AbbVie shares in Q4 2020, an estimated $97.5K.
  • AbbVie made up 3.45% of Hammer Asset Management's portfolio in Q4 2020, its #2 holding.
  • Hammer Asset Management first reported a position in AbbVie in Q2 2018 and has held it in 11 quarters since.
  • Hammer Asset Management's AbbVie position peaked at $7.33M in Q2 2018.
  • 2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Hammer Asset Management's 13F filing for Q4 2020, filed 19 Jan 2021.